Cancer BiologyJournal of Experimental MedicinePeer-reviewed
Developing High-Affinity Decoy Receptor Optimized for Multiple Myeloma and Diffuse Large B Cell Lymphoma Treatment
Y. R. Miao, K. Thakkar, C. Cenik…·A. J. Giaccia
This paper develops an engineered sBCMA-Fc fusion protein with enhanced binding affinity to APRIL and BAFF, showing improved antitumor activity against multiple myeloma and diffuse large B cell lymphoma in preclinical models.
DOI 10.1084/jem.20220214